| Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach (NCT00003157) | Alliance for Clinical Trials in Oncology | 1998-02-01 |
| Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors (NCT00003125) | Georgetown University | 1998-01-01 |
| Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer (NCT00251355) | Dana-Farber Cancer Institute | 1998-01-01 |
| Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer (NCT00544193) | City of Hope Medical Center | 1997-12-01 |
| Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors (NCT00019331) | National Cancer Institute (NCI) | 1997-10-01 |
| S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer (NCT00003018) | SWOG Cancer Research Network | 1997-09-01 |
| Interleukin-12 in Treating Patients With Cancer in the Abdomen (NCT00003046) | M.D. Anderson Cancer Center | 1997-08-01 |
| Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer (NCT00003332) | NYU Langone Health | 1997-07-01 |
| Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas (NCT00003049) | Mayo Clinic | 1997-05-01 |
| Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas (NCT00003029) | European Organisation for Research and Treatment of Cancer - EORTC | 1997-05-01 |
| Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer (NCT00003025) | Memorial Sloan Kettering Cancer Center | 1997-03-01 |
| Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer (NCT00004087) | Garden State Cancer Center at the Center for Molecular Medicine and Immunology | 1997-03-01 |
| Spectroscopy With Surface Coils and Decoupling (NCT00581815) | Memorial Sloan Kettering Cancer Center | 1997-02-01 |
| Biological Therapy in Treating Patients With Metastatic Cancer (NCT00004604) | Duke University | 1997-02-01 |
| Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer (NCT00003085) | University of Southern California | 1996-09-01 |
| Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer (NCT00002773) | St. Vincent Medical Center - Los Angeles | 1996-05-01 |
| Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer (NCT00019084) | National Cancer Institute (NCI) | 1996-02-01 |
| Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer (NCT00002689) | Center for Molecular Medicine | 1995-09-01 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas (NCT00002955) | University of Southern California | 1995-08-01 |
| Oral Microbiome and Pancreatic Cancer (NCT03302637) | NYU Langone Health | 1992-12-01 |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer (NCT00002475) | St. Vincent Medical Center - Los Angeles | 1991-04-01 |
| Pancreatic Disease Burden in Older Adults (1990-2040) (NCT07177599) | Changhai Hospital | 1990-01-01 |
| Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma (NCT07573215) | Revolution Medicines, Inc. | |
| Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer (NCT04087889) | Hope Biosciences LLC | |
| Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients (NCT05974410) | AVM Biotechnology Inc | |
| Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval (NCT06751524) | Agenus Inc. | |
| Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation (NCT03906331) | Eli Lilly and Company | |
| Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Carcinoma (NCT02449135) | Fuda Cancer Hospital, Guangzhou | |
| Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor (NCT04100694) | Merus B.V. | |
| Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas (NCT00116389) | Point Therapeutics | |
| BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast (NCT04091295) | Aveni Foundation | |
| SU006668 in Treating Patients With Advanced Solid Tumors (NCT00024063) | Jonsson Comprehensive Cancer Center | |
| A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003 (NCT00786058) | CONKO-Studiengruppe | |
| Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer (NCT01017822) | Radiation Therapy Oncology Group | |
| A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer (NCT00051467) | GenVec | |
| Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies (NCT04566393) | xCures | |
| Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery (NCT02446379) | Lightpoint Medical Limited | |
| Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer (NCT04137822) | Impatients N.V. trading as myTomorrows | |
| Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors (NCT06872489) | Second Life Therapeutics | |